Littoral Environnement et Sociétés (LIENSs), UMR 7266, CNRS-Université de La Rochelle, 2 Rue Olympe de Gouges, 17042, La Rochelle Cedex 01, France. tamas.malkocs@gmail.com.
Pál Juhász-Nagy Doctoral School of Biology and Environmental Sciences, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary. tamas.malkocs@gmail.com.
Institute of Biology and Ecology, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary. tamas.malkocs@gmail.com.
Institute of Aquatic Ecology, Centre for Ecological Research, 4026, Debrecen, Hungary. tamas.malkocs@gmail.com.
Ctedra Diversidad Animal I and Laboratorio de Virologa y Gentica Molecular; Facultad de Ciencias Naturales y Ciencias de la Salud; Universidad Nacional de la Patagonia San Juan Bosco; 9 de Julio y Belgrano s/n; 9100 Trelew; Chubut; ARGENTINA. jgloreley@gmail.com.
Museo Argentino de Ciencias Naturales Bernardino Rivadavia; Av. ngel Gallardo 470; C1405DJR Ciudad Autnoma de Buenos Aires; ARGENTINA. gpastorino@macn.gov.ar.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: gsmedley@iastate.edu.
Department of Zoology, University of São Paulo, Rua do Matão, Travessa 14, n. 101, 05508-090 São Paulo, SP, Brazil. Electronic address: jorgeaudino@ib.usp.br.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: courtney.grula@ndsu.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: aporathk@umn.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: apairett@iastate.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: aalejand@whittier.edu.
Faculty of Science, Health, Education, and Engineering, University of the Sunshine Coast, Maroochydore DC, Queensland 4558, Australia. Electronic address: felicity.masters@research.usc.edu.au.
Faculty of Science, Health, Education, and Engineering, University of the Sunshine Coast, Maroochydore DC, Queensland 4558, Australia. Electronic address: pduncan@usc.edu.au.
Department of Invertebrate Zoology, National Museum of National History, Smithsonian Institution, 10th and Constitution Ave NW, Washington, DC 20560, USA. Electronic address: StrongE@si.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: serb@iastate.edu.
Clostridioides difficile colitis is an important source of hospital-acquired diarrhea associated with antibiotic use. Symptoms are profuse watery diarrhea, typically following a course of antibiotics;...
Clostridioides difficile (C. difficile) is a common hospital-acquired infection which can lead to major implications for patients and our health care system. In this study, we examine a policy change ...
The time to receive results and initiate treatment were analyzed before and after the policy change, and between physicians and nurses using descriptive statistics and paired student t-tests. Variable...
The difference in time to obtain the result both before and after the policy change and between ordering provider type were both statistically significant (P < .05). In unadjusted models, nurses were ...
Allowing bedside nurses more autonomy to order the stool sample significantly decreased the amount of time to receive the results, potentially decreasing the risk of additional infections among patien...
Clostridioides difficile (formerly known as Clostridium difficile) is a bacterium that can cause potentially life-threatening diarrheal illness in individuals with an unhealthy mixture of gut bacteria...
To evaluate the benefits and harms of donor-based fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile infection in immunocompetent people....
We used standard, extensive Cochrane search methods. The latest search date was 31 March 2022....
We considered randomized trials of adults or children with rCDI for inclusion. Eligible interventions must have met the definition of FMT, which is the administration of fecal material containing dist...
We used standard Cochrane methods. Our primary outcomes were 1. proportion of participants with resolution of rCDI and 2. serious adverse events. Our secondary outcomes were 3. treatment failure, 4. a...
We included six studies with 320 participants. Two studies were conducted in Denmark, and one each in the Netherlands, Canada, Italy, and the US. Four were single-center and two were multicenter studi...
In immunocompetent adults with rCDI, FMT likely leads to a large increase in the resolution of recurrent Clostridioides difficile infection compared to alternative treatments such as antibiotics. Ther...
Clostridioides (Clostridium) difficile causes antimicrobial-associated diarrhoea, however, presentations may range from asymptomatic carriage to severe diarrhoea, life-threatening toxic megacolon and ...
Diarrhoeal stool samples from adult patients aged ≥17 years old were collected at Thai Binh General Hospital in northern Vietnam between March 1, 2021 and February 28, 2022. All samples were transport...
A total of 205 stool samples were collected from patients aged from 17 to 101 years old. The overall prevalence of C. difficile was 15.1% (31/205) with the recovery of toxigenic and non-toxigenic isol...
The prevalence of C. difficile in adults with diarrhoea and multidrug resistance in C. difficile isolates was relatively high. A clinical assessment to differentiate between CDI/disease and colonisati...
Clostridioides difficile is the leading health care-associated pathogen, leading to substantial morbidity and mortality; however, there is no widely accepted model to predict C. difficile infection se...
To investigate the epidemiology of Clostridioides difficile infection (CDI) in Slovakian hospitals after the emergence of ribotype 176 (027-like) in 2016....
Between 2018 and 2019, European Centre for Disease Control and Prevention CDI surveillance protocol v2.3 was applied to 14 hospitals, with additional data collected on recent antimicrobial use and the...
The mean hospital incidence of CDI was 4.1 cases per 10,000 patient bed-days. One hundred and five (27.6%) in-hospital deaths were reported among the 381 cases. Antimicrobial treatment within the prev...
The newly-predominant RT176 and endemic RT001 are driving the epidemiology of CDI in Slovakia. In addition to fluoroquinolones, the use of macrolide-lincosamide-streptogramin B antibiotics can represe...
Clostridioides difficile infection (CDI) is a significant worry within healthcare institutions and the community. It is one of the leading agents causing severe diarrhea worldwide. Effective managemen...
Clostridioides difficile infection (CDI) is the most common hospital acquired infection in the USA, with recurrence rates > 15%. Although primary CDI has been extensively linked to gut microbial dysbi...
We conducted a prospective, longitudinal study of 53 non-immunocompromised participants with primary CDI. Stool sample collection began pre-CDI antibiotic treatment at the time of diagnosis, and conti...
The prospective, longitudinal, and multi-omic nature of our CDI recurrence study allowed us to uncover previously unrecognized dynamics in the microbiome and host presaging recurrence, and, in particu...